What is new in 2011 regarding testicular cancer

被引：0
作者：
Krege, S. [1 ]
机构：
[1] Alexianer Krankenhaus Maria Hilf GmbH Krefeld, Klin Urol & Kinderurol, D-47805 Krefeld, Germany
来源：
UROLOGE | 2011年 / 50卷
关键词：
Testicular cancer; Primary tumor resection; organ-preserving; Secondary malignancies; High-dose therapy; Residual tumor resection; GERM-CELL TUMORS; LYMPH-NODE DISSECTION; POSITRON-EMISSION-TOMOGRAPHY; ORGAN-SPARING SURGERY; RANDOMIZED-TRIAL; TESTIS CANCER; CHEMOTHERAPY; SURVEILLANCE; MANAGEMENT; RESECTION;
D O I：
10.1007/s00120-011-2671-y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The management of testicular cancer has already been standardized to the greatest extent by consistent performance of clinical trials. While the current aim is to reduce the therapy for early stage disease without jeopardizing the high cure rates, for patients in advanced stages the goal is to achieve further improvement of survival rates. This overview presents new aspects of organ-preserving primary tumor resection, prognostic factors in seminoma, secondary malignancies, high-dose therapy, residual tumor resection, aftercare, and PET/CT.
引用
收藏
页码：187 / 191
页数：5
相关论文
共 33 条
[1]   Risk-adapted management of stage I seminoma: Results of the third Spanish Germ Cell Cancer Group study [J].
Aparicio, J. ;
Robert, L. ;
Garcia del Muro, X. ;
Guma, J. ;
Sanchez, A. ;
Margeli, M. ;
Domenech, M. ;
Bastus, R. ;
Maroto, J. P. ;
Germa-Lluch, J. R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[2]   Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis [J].
Besse, Benjamin ;
Grunenwald, Dominique ;
Flechon, Aude ;
Caty, Armelle ;
Chevreau, Christine ;
Culine, Stephane ;
Theodore, Christine ;
Fizazi, Karim .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (02) :448-452
[3]   Population-based Study of Perioperative Mortality After Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Germ Cell Tumors [J].
Capitanio, Umberto ;
Jeldres, Claudio ;
Perrotte, Paul ;
Isbarn, Hendrik ;
Crepel, Maxime ;
Cloutier, Vincent ;
Baillargeon-Gagne, Sara ;
Shariat, Shahrokh F. ;
Duclos, Alain ;
Arjane, Philippe ;
Widmer, Hugues ;
Saad, Fred ;
Montorsi, Francesco ;
Karakiewicz, Pierre I. .
UROLOGY, 2009, 74 (02) :373-377
[4]  
CHUNG PW, 2010, J CLIN ORTHOP, V28, P535
[5]   2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma:: An update of the prospective multicentric SEMPET trial [J].
De Santis, M ;
Becherer, A ;
Bokemeyer, C ;
Stoiber, F ;
Oechsle, K ;
Sellner, F ;
Lang, A ;
Kletter, K ;
Dohmen, BM ;
Dittrich, C ;
Pont, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1034-1039
[6]   Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection [J].
Ehrlich, Yaron ;
Yossepowitch, Ofer ;
Kedar, Daniel ;
Baniel, Jack .
BJU INTERNATIONAL, 2006, 97 (06) :1221-1224
[7]   Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission? [J].
Ehrlich, Yaron ;
Brames, Mary J. ;
Beck, Stephen D. W. ;
Foster, Richard S. ;
Einhorn, Lawrence H. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :531-536
[8]   Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour [J].
Flechon, Aude ;
Tavernier, Emmanuelle ;
Boyle, Helen ;
Meeus, Pierre ;
Rivoire, Michel ;
Droz, Jean-Pierre .
BJU INTERNATIONAL, 2010, 106 (06) :779-785
[9]  
HARTMANN M, 2011, UROLOGE IN PRESS
[10]   Cardiovascular risk in long-term testicular cancer survivors [J].
Haugnes, H. S. ;
Wethal, T. ;
Aass, N. ;
Dahl, O. ;
Klepp, O. H. ;
Langberg, C. ;
Wilsgaard, T. ;
Bremnes, R. M. ;
Fossa, S. D. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
1234